000 01497 a2200397 4500
005 20250517125231.0
264 0 _c20170613
008 201706s 0 0 eng d
022 _a1879-3649
024 7 _a10.1016/j.vph.2016.11.007
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aCai, Meng
245 0 0 _aHeterodimerisation between VEGFR-1 and VEGFR-2 and not the homodimers of VEGFR-1 inhibit VEGFR-2 activity.
_h[electronic resource]
260 _bVascular pharmacology
_c01 2017
300 _a11-20 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnimals
650 0 4 _aEndothelial Cells
_xmetabolism
650 0 4 _aHuman Umbilical Vein Endothelial Cells
_xmetabolism
650 0 4 _aHumans
650 0 4 _aNeovascularization, Physiologic
_xphysiology
650 0 4 _aPhosphatidylinositol 3-Kinase
_xmetabolism
650 0 4 _aPhosphorylation
650 0 4 _aProtein Multimerization
650 0 4 _aSignal Transduction
650 0 4 _aSwine
650 0 4 _aVascular Endothelial Growth Factor A
_xmetabolism
650 0 4 _aVascular Endothelial Growth Factor Receptor-1
_xmetabolism
650 0 4 _aVascular Endothelial Growth Factor Receptor-2
_xmetabolism
700 1 _aWang, Keqing
700 1 _aMurdoch, Colin E
700 1 _aGu, Yuchun
700 1 _aAhmed, Asif
773 0 _tVascular pharmacology
_gvol. 88
_gp. 11-20
856 4 0 _uhttps://doi.org/10.1016/j.vph.2016.11.007
_zAvailable from publisher's website
999 _c26637913
_d26637913